Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Heat Biologics Inc (HTBX)

Heat Biologics Inc (HTBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 183,732
  • Shares Outstanding, K 84,669
  • Annual Sales, $ 3,050 K
  • Annual Income, $ -20,020 K
  • 60-Month Beta 0.84
  • Price/Sales 58.59
  • Price/Cash Flow N/A
  • Price/Book 6.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.08
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.04 +102.88%
on 07/15/20
4.30 -50.93%
on 07/21/20
+1.10 (+108.91%)
since 07/10/20
3-Month
0.53 +298.04%
on 05/11/20
4.30 -50.93%
on 07/21/20
+1.58 (+298.94%)
since 05/08/20
52-Week
0.19 +982.05%
on 02/27/20
4.30 -50.93%
on 07/21/20
+1.49 (+240.27%)
since 08/09/19

Most Recent Stories

More News
Patient Monitoring Capabilities Expand Treatment Possibilities

, /PRNewswire/ -- The patient monitoring device market is a large and diverse segment of the medical device industry. Traditionally, patient monitoring devices were used in hospitals to monitor patient's...

HTBX : 2.11 (-2.76%)
INOTF : 0.0300 (+13.64%)
NVAX : 178.51 (+4.83%)
VXRT : 9.40 (+2.29%)
NMRD : 5.49 (-4.69%)
PHG : 52.03 (-1.08%)
Thinking about buying stock in Lyft Inc, Heat Biologics, Canopy Growth Corp, Sorrento Therapeutics, or Delta Air Lines?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LYFT, HTBX, CGC, SRNE, and DAL.

CGC : 17.93 (+7.82%)
DAL : 29.34 (+7.95%)
HTBX : 2.11 (-2.76%)
SRNE : 18.82 (+30.51%)
Heat Biologics Provides Second Quarter 2020 Business Update

, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today...

HTBX : 2.11 (-2.76%)
Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19

White paper highlights potential of Heat's vaccine to boost T cell immunity, alone or in combination with other vaccines

HTBX : 2.11 (-2.76%)
MOST Popular Stocks Robinhood Investors Are Buying Today

The most popular stocks over the past 24 hours on the Robinhood platform are Eastman Kodak (KODK), Kandi Technologies Group (KNDI), and Heat Biologics (HTBX). Learn why. In some circles, the stock...

KODK : 10.73 (-27.89%)
KNDI : 8.90 (-1.77%)
HTBX : 2.11 (-2.76%)
TSLA : 1,418.57 (-2.35%)
Thinking about buying stock in Heat Biologics, IZEA Worldwide, Ocugen Inc, Trevena Inc, or Delta Air Lines?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HTBX, IZEA, OCGN, TRVN, and DAL.

DAL : 29.34 (+7.95%)
HTBX : 2.11 (-2.76%)
TRVN : 3.13 (+31.51%)
Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies

Confirms stimulation of human-HLA-restricted transgenic mouse T-cells against immunodominant epitopes of SARS-CoV-2 Spike protein

HTBX : 2.11 (-2.76%)
Government Efforts to Mitigate Fallout Accentuate the Need for Expanded Testing Capabilities

, /PRNewswire/ --  The pandemic continues to devastate the economy as well as healthcare systems around the world. In response to the outbreak, governments have focused their resources on treatment and...

TOMDF : 0.1100 (+23.60%)
AYTU : 1.3750 (-0.36%)
IBIO : 3.69 (-2.89%)
HTBX : 2.11 (-2.76%)
TNXP : 1.1200 (-3.45%)
Thinking about buying stock in Sogou Inc, Xperi Holding Corp, Ampio Pharmaceuticals, Heat Biologics, or Arbutus Biopharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOGO, XPER, AMPE, HTBX, and ABUS.

AMPE : 1.0100 (-0.98%)
ABUS : 3.66 (-3.68%)
HTBX : 2.11 (-2.76%)
Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule

DURHAM, NC / ACCESSWIRE / July 27, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,...

HTBX : 2.11 (-2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade HTBX with:

Business Summary

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell...

See More

Key Turning Points

2nd Resistance Point 2.18
1st Resistance Point 2.14
Last Price 2.11
1st Support Level 2.07
2nd Support Level 2.04

See More

52-Week High 4.30
Fibonacci 61.8% 2.73
Fibonacci 50% 2.25
Last Price 2.11
Fibonacci 38.2% 1.76
52-Week Low 0.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar